Latest Eris Lifesciences stock price
Eris Lifesciences P/E Ratio
ERIS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
47.08
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
47.08
Current Price
₹1534.40
EPS (TTM)
₹25.85
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
28.13
Historical Range
19.65 - 37.4
Percentile
100.0%
Sector Context
Sector Average
57.44
Sector Median
35.38
Sector Rank
#11 of 88
Sector Percentile
12.5%
Earnings Breakdown (TTM)
TTM EPS
₹31.11
Sept 2025
₹8.82
Mar 2025
₹6.90
Key P/E Ratio Insights for Eris Lifesciences
- Stock appears overvalued with PE of 47.08, suggesting caution for new investments
- Current PE is 67.4% above historical average
- Trading at discount to sector average PE of 57.44
View the ERIS equity price for detailed stock performance.
P/E Ratio Historical Trend for Eris Lifesciences
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Eris Lifesciences
Additional stock information and data for ERIS
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 37.4 | 24.22 | ₹905.80 | NSE | High |
| 2023 | 23.39 | 28.41 | ₹664.65 | NSE | Moderate |
| 2022 | 26.18 | 29.2 | ₹764.35 | NSE | High |
| 2021 | 20.34 | 29.01 | ₹590.10 | NSE | Moderate |
| 2020 | 19.65 | 25.26 | ₹496.40 | NSE | Moderate |
| 2019 | 32.34 | 21.4 | ₹692.15 | NSE | High |
| 2018 | 36.85 | 21.27 | ₹783.85 | NSE | High |
| 2017 | 28.88 | 20.76 | ₹599.50 | NSE | High |
Sector P/E Ratio Comparison
Comparing Eris Lifesciences with other companies in Healthcare sector
Sector Average
57.44
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |